Semax / Selank (Mezcla)

Semax / Selank Blend is a research peptide combination consisting of Semax (a synthetic ACTH-derived peptide analog) and Selank (a synthetic tuftsin analog peptide), formulated in equal 5mg/5mg concentration for laboratory study. In controlled research environments, this peptide blend has been investigated for its interaction with neuropeptide signaling pathways, neurotransmitter modulation mechanisms, and cognitive regulatory research models. Due to their distinct yet complementary molecular profiles, the combination remains a compound of interest in neurobiology and central nervous system signaling research.

Preclinical investigations have examined Semax for its influence on neurotrophic factor expression pathways, while Selank has been studied for its interaction with GABAergic signaling mechanisms and immune-neuroendocrine modulation research. Ongoing laboratory evaluations continue to explore receptor interaction dynamics, synaptic signaling pathways, and cellular communication frameworks within experimental neuroscience settings.

This research peptide blend is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural consistency. Semax / Selank Blend is intended strictly for laboratory research and analytical purposes only and is not for human consumption.